1. Intravitreal Bevacizumab in Aggressive Posterior Retinopathy of Prematurity
- Author
-
Isabel Prieto, Isaura Regadas, A Valido, Maria do Céu Machado, Florinod Esteves Esperancinha, Graça Pires, Robert van Velze, Pinto Ferreira, António Travassos, Ana Travassos, and Susana Teixeira
- Subjects
Vascular Endothelial Growth Factor A ,medicine.medical_specialty ,genetic structures ,Bevacizumab ,Angiogenesis Inhibitors ,Gestational Age ,Antibodies, Monoclonal, Humanized ,Injections ,chemistry.chemical_compound ,Laser therapy ,Ophthalmology ,medicine ,Humans ,Infant, Very Low Birth Weight ,Retinopathy of Prematurity ,Tunica vasculosa lentis ,Intravitreal bevacizumab ,business.industry ,Infant, Newborn ,Antibodies, Monoclonal ,Retinopathy of prematurity ,Retinal ,medicine.disease ,eye diseases ,Vitreous Body ,Plus disease ,Treatment Outcome ,chemistry ,sense organs ,business ,Infant, Premature ,medicine.drug - Abstract
The anatomic response to intravitreal bevacizumab injection in three patients with aggressive, posterior retinopathy of prematurity is described. In all cases, the worse eye was treated with a single intravitreal injection of 0.75 mg of bevacizumab as monotherapy or complementary to laser therapy. In 24 hours, all injected eyes showed regression of the tunica vasculosa lentis and iris vessel engorgement and disappearance of iris rigidity. In addition, plus disease and retinal proliferation began to regress. None of the eyes required additional treatment. Follow-up of up to 10 months showed good anatomic outcomes and no evidence of local or systemic adverse events. [Ophthalmic Surg Lasers Imaging 2007;38:233-237.] AUTHORS From the Pediatric Retina Department (ST, FEE, IP, GP), Ophthalmology Service, Hospital Fernando Fonseca, Lisbon; the Surgical Center of Coimbra (AT, IR, AST, RV), Coimbra; the Ophthalmology Department (PF), Centro Hospitalar de Lisboa, Zona Central, Hospital de S. José, Lisbon; Alfredo da Costa Maternity (AV), Lisbon; and the High Commissary for Portuguese Health (MCM), Lisbon, Portugal. Accepted for publication February 26, 2007. Presented at the World ROP Meeting, Vilnius, Lithuania, September 14-16, 2006. Abstract number 015. The authors thank Drs. Stephan Michels and Rike Michels for their support. Address correspondence to Susana Teixeira, MD, Pediatric Retina Department at the Service of Ophthalmology, Hospital Fernando Fonseca, R. João de Freitas Branco nº 21, 6º D, 1500-714 Lisboa, Portugal. E-mail: susanateixeira.oft@gmail.com.
- Published
- 2007
- Full Text
- View/download PDF